APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bone Morphogenetic Protein (BMP) 2

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

Selected research

Market Outlook & Growth Opportunities

Global Bone Morphogenetic Protein (BMP) 2 Market Outlook and Growth Opportunities 2026

Report ID 173971960423 December 2025199 pages

Choose your research edition.

Industry ResearchBone Morphogenetic Protein (BMP) 2 Industry Research Report 2026102 pages · $2,950 USDIndustry Growth & TrendsGlobal Bone Morphogenetic Protein (BMP) 2 Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Bone Morphogenetic Protein (BMP) 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bone Morphogenetic Protein (BMP) 2 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Bone Morphogenetic Protein (BMP) 2 Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

According to types, the most proportion of the Bone Morphogenetic Protein (BMP) 2 is Sponge, taking almost 99% sales share of global market in 2020. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used for Spinal Fusion and the proportion is about 66% in 2020. Global market of BMP 2 is extremely intensive. Medtronic, Jiuyuan Gene Engineering and Cellumed are the only 3 companies supplying this product. Furthermore, among these companies, Medtronic takes almost 95% share of global market.

This report provides an overview of the global Bone Morphogenetic Protein (BMP) 2 market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Bone Morphogenetic Protein (BMP) 2 and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bone Morphogenetic Protein (BMP) 2 revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bone Morphogenetic Protein (BMP) 2 market.

Bone Morphogenetic Protein (BMP) 2 Segment by Company

Medtronic

Jiuyuan Gene Engineering

Cellumed

Bone Morphogenetic Protein (BMP) 2 Segment by Type

Sponge

Gel

Bone Morphogenetic Protein (BMP) 2 Segment by Application

Spinal Fusion

Trauma Surgery

Oral Maxillofacial Surgery

Reconstructive Surgery

Bone Morphogenetic Protein (BMP) 2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bone Morphogenetic Protein (BMP) 2 status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bone Morphogenetic Protein (BMP) 2 key companies, revenue, market share, and recent developments.

3. To split the Bone Morphogenetic Protein (BMP) 2 breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bone Morphogenetic Protein (BMP) 2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bone Morphogenetic Protein (BMP) 2 significant trends, drivers, influence factors in global and regions.

6. To analyze Bone Morphogenetic Protein (BMP) 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bone Morphogenetic Protein (BMP) 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bone Morphogenetic Protein (BMP) 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bone Morphogenetic Protein (BMP) 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bone Morphogenetic Protein (BMP) 2 industry.

Chapter 3: Detailed analysis of Bone Morphogenetic Protein (BMP) 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bone Morphogenetic Protein (BMP) 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bone Morphogenetic Protein (BMP) 2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bone Morphogenetic Protein (BMP) 2 Industry Trends Table 2. Bone Morphogenetic Protein (BMP) 2 Industry Drivers Table 3. Bone Morphogenetic Protein (BMP) 2 Industry Opportunities and Challenges Table 4. Bone Morphogenetic Protein (BMP) 2 Industry Restraints Table 5. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bone Morphogenetic Protein (BMP) 2 Revenue Share by Company (2021-2026) Table 7. Global Bone Morphogenetic Protein (BMP) 2 Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bone Morphogenetic Protein (BMP) 2 Key Company Manufacturing Base & Headquarters Table 9. Global Bone Morphogenetic Protein (BMP) 2 Company, Product Type & Application Table 10. Global Bone Morphogenetic Protein (BMP) 2 Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bone Morphogenetic Protein (BMP) 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Sponge Table 15. Significant Companies of Gel Table 16. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type (2021-2026) Table 20. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Spinal Fusion Table 22. Significant Companies of Trauma Surgery Table 23. Significant Companies of Oral Maxillofacial Surgery Table 24. Significant Companies of Reconstructive Surgery Table 25. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application (2021-2026) Table 29. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application (2027-2032) Table 30. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Region (2021-2026) Table 33. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Region (2027-2032) Table 35. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Market Share by Country (2021-2026) Table 38. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Market Share by Country (2027-2032) Table 40. Medtronic Company Information Table 41. Medtronic Business Overview Table 42. Medtronic Bone Morphogenetic Protein (BMP) 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Medtronic Bone Morphogenetic Protein (BMP) 2 Product Portfolio Table 44. Medtronic Recent Development Table 45. Jiuyuan Gene Engineering Company Information Table 46. Jiuyuan Gene Engineering Business Overview Table 47. Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Product Portfolio Table 49. Jiuyuan Gene Engineering Recent Development Table 50. Cellumed Company Information Table 51. Cellumed Business Overview Table 52. Cellumed Bone Morphogenetic Protein (BMP) 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Cellumed Bone Morphogenetic Protein (BMP) 2 Product Portfolio Table 54. Cellumed Recent Development Table 55. Research Programs/Design for This Report Table 56. Authors List of This Report Table 57. Secondary Sources Table 58. Primary Sources List of Figures Figure 1. Bone Morphogenetic Protein (BMP) 2 Product Image Figure 2. Global Bone Morphogenetic Protein (BMP) 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bone Morphogenetic Protein (BMP) 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Bone Morphogenetic Protein (BMP) 2 Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Sponge Image Figure 8. Gel Image Figure 9. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type (2021-2032) Figure 12. Spinal Fusion Image Figure 13. Trauma Surgery Image Figure 14. Oral Maxillofacial Surgery Image Figure 15. Reconstructive Surgery Image Figure 16. Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application (2021-2032) Figure 19. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Bone Morphogenetic Protein (BMP) 2 Sales Value (2021-2032) & (US$ Million) Figure 22. North America Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Bone Morphogenetic Protein (BMP) 2 Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Bone Morphogenetic Protein (BMP) 2 Sales Value (2021-2032) & (US$ Million) Figure 28. South America Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Sponge
  • Gel
Applications
  • Spinal Fusion
  • Trauma Surgery
  • Oral Maxillofacial Surgery
  • Reconstructive Surgery
Companies covered
  • Medtronic
  • Jiuyuan Gene Engineering
  • Cellumed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bone Morphogenetic Protein (BMP) 2 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bone Morphogenetic Protein (BMP) 2 Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bone Morphogenetic Protein (BMP) 2 Market Dynamics
  1. 2.1 Bone Morphogenetic Protein (BMP) 2 Industry Trends
  2. 2.2 Bone Morphogenetic Protein (BMP) 2 Industry Drivers
  3. 2.3 Bone Morphogenetic Protein (BMP) 2 Industry Opportunities and Challenges
  4. 2.4 Bone Morphogenetic Protein (BMP) 2 Industry Restraints
3 Bone Morphogenetic Protein (BMP) 2 Market by Company
  1. 3.1 Global Bone Morphogenetic Protein (BMP) 2 Company Revenue Ranking in 2025
  2. 3.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Company (2021-2026)
  3. 3.3 Global Bone Morphogenetic Protein (BMP) 2 Company Ranking (2024-2026)
  4. 3.4 Global Bone Morphogenetic Protein (BMP) 2 Company Manufacturing Base and Headquarters
  5. 3.5 Global Bone Morphogenetic Protein (BMP) 2 Company Product Type and Application
  6. 3.6 Global Bone Morphogenetic Protein (BMP) 2 Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bone Morphogenetic Protein (BMP) 2 Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bone Morphogenetic Protein (BMP) 2 Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bone Morphogenetic Protein (BMP) 2 Market by Type
  1. 4.1 Bone Morphogenetic Protein (BMP) 2 Type Introduction
  2. 4.1.1 Sponge
  3. 4.1.2 Gel
  4. 4.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Type
  5. 4.2.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Type (2021-2032)
  7. 4.2.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type (2021-2032)
5 Bone Morphogenetic Protein (BMP) 2 Market by Application
  1. 5.1 Bone Morphogenetic Protein (BMP) 2 Application Introduction
  2. 5.1.1 Spinal Fusion
  3. 5.1.2 Trauma Surgery
  4. 5.1.3 Oral Maxillofacial Surgery
  5. 5.1.4 Reconstructive Surgery
  6. 5.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Application
  7. 5.2.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Application (2021-2032)
  9. 5.2.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application (2021-2032)
6 Bone Morphogenetic Protein (BMP) 2 Regional Value Analysis
  1. 6.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bone Morphogenetic Protein (BMP) 2 Sales Value (2021-2032)
  7. 6.3.2 North America Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bone Morphogenetic Protein (BMP) 2 Sales Value (2021-2032)
  10. 6.4.2 Europe Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bone Morphogenetic Protein (BMP) 2 Sales Value (2021-2032)
  16. 6.6.2 South America Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country, 2025 VS 2032
7 Bone Morphogenetic Protein (BMP) 2 Country-level Value Analysis
  1. 7.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Bone Morphogenetic Protein (BMP) 2 Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Jiuyuan Gene Engineering
  8. 8.2.1 Jiuyuan Gene Engineering Company Information
  9. 8.2.2 Jiuyuan Gene Engineering Business Overview
  10. 8.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Product Portfolio
  12. 8.2.5 Jiuyuan Gene Engineering Recent Developments
  13. 8.3 Cellumed
  14. 8.3.1 Cellumed Company Information
  15. 8.3.2 Cellumed Business Overview
  16. 8.3.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cellumed Bone Morphogenetic Protein (BMP) 2 Product Portfolio
  18. 8.3.5 Cellumed Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst